Search

Author/Creator Lukas, Milan

3. ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS. (22nd January 2022)

Authors:
Cerna, Karin; Duricova, Dana; Lukas, Martin; Machkova, Nadezda; Hruba, Veronika; Lukas, Milan
Journal:
Inflammatory bowel diseases
Issue:
Volume 28(2022)Supplement 1
Page Start:
S101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study. Issue 10 (30th November 2021)

Authors:
Cerna, Karin; Duricova, Dana; Lukas, Martin; Machkova, Nadezda; Hruba, Veronika; Mitrova, Katarina; Kubickova, Kristyna; Kostrejova, Marta; Teplan, Vladimir; Vasatko, Martin; Kastylova, Kristyna; Lukas, Milan
Journal:
Inflammatory bowel diseases
Issue:
Volume 28:Issue 10(2022)
Page Start:
1506
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Issue 6 (13th May 2010)

Authors:
Reinisch, Walter; Angelberger, Sieglinde; Petritsch, Wolfgang; Shonova, Olga; Lukas, Milan; Bar-Meir, Simon; Teml, Alexander; Schaeffeler, Elke; Schwab, Matthias; Dilger, Karin; Greinwald, Roland; Mueller, Ralph; Stange, Eduard F; Herrlinger, Klaus R
Journal:
Gut
Issue:
Volume 59:Issue 6(2010)
Page Start:
752
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients. (31st March 2022)

Authors:
Cerna, Karin; Duricova, Dana; Hindos, Miroslav; Hindos Hrebackova, Jana; Lukas, Martin; Machkova, Nadezda; Hruba, Veronika; Mitrova, Katarina; Kubickova, Kristyna; Kastylova, Kristyna; Teplan, Vladimir; Lukas, Milan
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16:Number 9(2022)
Page Start:
1347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease. (24th November 2018)

Authors:
de Jong, Marin J; Roosen, Danielle; Degens, Juliette H R J; van den Heuvel, Tim R A; Romberg-Camps, Marielle; Hameeteman, W; Bodelier, Alexander G L; Romanko, Igor; Lukas, Milan; Winkens, Bjorn; Markus, Tineke; Masclee, Ad A M; van Tubergen, Astrid; Jonkers, Daisy M A E; Pierik, Marie J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13:Number 5(2019)
Page Start:
555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study. (August 2021)

Authors:
Mitrova, Katarina; Pipek, Barbora; Bortlik, Martin; Bouchner, Ludek; Brezina, Jan; Douda, Tomas; Drasar, Tomas; Drastich, Pavel; Falt, Premysl; Klvana, Pavel; Leksa, Vaclav; Novotny, Ales; Svoboda, Pavel; Skorpik, Jan; Ulbrych, Jan; Veinfurt, Marek; Zborilova, Blanka; Lukas, Milan; Duricova, Dana
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation. (1st February 2016)

Authors:
Bortlik, Martin; Duricova, Dana; Machkova, Nadezda; Hruba, Veronika; Lukas, Martin; Mitrova, Katarina; Romanko, Igor; Bina, Vladislav; Malickova, Karin; Kolar, Martin; Lukas, Milan
Journal:
Scandinavian journal of gastroenterology
Issue:
Volume 51:Number 2(2016)
Page Start:
196
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms. (10th April 2021)

Authors:
Ungar, Bella; Malickova, Karin; Hanžel, Jurij; Abu Arisha, Muhammad; Paul, Stephane; Rocha, Catia; Ben Shatach, Zohar; Abitbol, Chaya Mushka; Haj Natour, Ola; Selinger, Limor; Yavzori, Miri; Fudim, Ella; Picard, Orit; Shoval, Irit; Eliakim, Rami; Kopylov, Uri; Magro, Fernando; Roblin, Xavier; Cho...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15:Number 10(2021)
Page Start:
1707
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗